Suggestions
Floris Engelhardt
Committed to creating conditions for change
Floris Engelhardt is a Postdoctoral Researcher with a focus on Biomolecular Design and DNA Nanotechnology. He is passionate about transforming visions into scientific breakthroughs and applying them to real-world scenarios. His academic journey includes a Master of Science in Molekulare Biotechnologie from the Technische Universität München, an Erasmus exchange program at the University of York, and a Bachelor of Science in Biochemistry and Molecular Biology from Friedrich-Schiller-Universität Jena. Floris has been associated with prestigious institutions such as the Massachusetts Institute of Technology and the Technische Universität München in various research capacities.
As a Global Entrepreneur in Residence at the University of Massachusetts Boston, Floris Engelhardt brings his expertise in entrepreneurship and research to foster innovation. Prior to this role, he served as an Entrepreneurial Research Fellow at Activate Boston and held positions as a Postdoctoral Research Fellow and a PHD Student at Technische Universität München. Floris Engelhardt's diverse experiences across academia and entrepreneurship have equipped him with a unique skill set to drive cutting-edge research in Biomolecular Design and DNA Nanotechnology.
Floris Engelhardt's multidisciplinary background in biotechnology, biochemistry, and molecular biology positions him as a versatile researcher capable of bridging the gap between theory and practical applications. His track record of academic achievements and industry engagements underscores his commitment to advancing scientific knowledge and translating it into tangible solutions. Floris's collaborative spirit and innovative mindset make him a valuable asset in the realm of biomolecular research and nanotechnology.
Highlights
In 2021, during the Nucleate Activator program, I first discovered Endpoints News — proof of how new I was to biopharma! Now, after being a subscriber for three years, I have the opportunity to share this article with you, written by the phenomenal Ryan Cross.
https://lnkd.in/ePnx9TfD
I need thank my co-founders John Vroom, Mark Bathe and some special organizations that have guided me from coming to the US in 2020 to leading an organization with the most fantastic scientists and developing therapeutic opportunities for gene insertions at Kano Therapeutics.
Massachusetts Institute of Technology, UMass Boston, Activate, The Termeer Foundation, The Engine, Engine Ventures, Vsquared Ventures, Amino Collective, Metaplanet, Taihill Venture
